Sven Dethlefs Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

TEVA Quotes by TradingView

Sven Dethlefs is EVP, North America Commercial of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 165,381 shares of TEVA, which is worth approximately $2.97 Million. The most recent transaction as insider was on Mar 07, 2023, when has been sold 58,066 shares (Ordinary Shares) at a price of $9.43 per share, resulting in proceeds of $547,562. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K
0% 3M change
0% 12M change
Total Value Held $2.97 Million

Sven Dethlefs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2023
SELL
Open market or private sale
$547,562 $9.43 p/Share
58,066 Reduced 25.99%
165,381 Ordinary Shares
Mar 06 2023
SELL
Open market or private sale
$192,195 $9.93 p/Share
19,355 Reduced 7.97%
223,447 Ordinary Shares
Mar 05 2023
BUY
Exercise of conversion of derivative security
-
24,952 Added 9.32%
242,802 Ordinary Shares
Mar 04 2023
BUY
Exercise of conversion of derivative security
-
52,469 Added 19.41%
217,850 Ordinary Shares
Feb 28 2023
SELL
Open market or private sale
$589,987 $9.89 p/Share
59,655 Reduced 26.51%
165,381 Ordinary Shares
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
59,655 Added 22.31%
207,690 Ordinary Shares
Mar 07 2022
SELL
Open market or private sale
$51,538 $7.37 p/Share
6,993 Reduced 4.06%
165,381 Ordinary Shares
Mar 05 2022
BUY
Exercise of conversion of derivative security
-
24,952 Added 12.65%
172,374 Ordinary Shares
Mar 04 2022
SELL
Open market or private sale
$29,202 $7.48 p/Share
3,904 Reduced 2.58%
147,422 Ordinary Shares
Mar 04 2022
BUY
Exercise of conversion of derivative security
-
51,869 Added 25.53%
151,326 Ordinary Shares
Feb 28 2022
SELL
Open market or private sale
$39,577 $8.14 p/Share
4,862 Reduced 4.66%
99,457 Ordinary Shares
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
17,346 Added 14.26%
104,319 Ordinary Shares
Feb 09 2022
SELL
Open market or private sale
$37,490 $9.06 p/Share
4,138 Reduced 4.54%
86,973 Ordinary Shares
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
13,135 Added 12.6%
91,111 Ordinary Shares
Mar 04 2021
SELL
Open market or private sale
$63,547 $10.57 p/Share
6,012 Reduced 7.16%
77,975 Ordinary Shares
Mar 04 2021
BUY
Exercise of conversion of derivative security
-
13,930 Added 14.23%
83,987 Ordinary Shares
Mar 03 2021
SELL
Open market or private sale
$6,581 $10.86 p/Share
606 Reduced 0.86%
70,057 Ordinary Shares
Mar 03 2021
BUY
Exercise of conversion of derivative security
-
1,400 Added 1.94%
70,663 Ordinary Shares
Mar 01 2021
SELL
Open market or private sale
$81,073 $10.83 p/Share
7,486 Reduced 9.75%
69,263 Ordinary Shares
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
17,346 Added 18.43%
76,749 Ordinary Shares
Feb 09 2021
SELL
Open market or private sale
$376,347 $12.69 p/Share
29,657 Reduced 33.3%
59,403 Ordinary Shares
Feb 09 2021
BUY
Grant, award, or other acquisition
-
55,287 Added 38.3%
89,060 Ordinary Shares
Feb 09 2021
BUY
Exercise of conversion of derivative security
-
13,135 Added 28.0%
33,773 Ordinary Shares
SD

Sven Dethlefs

EVP, North America Commercial
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TEVA